Press Releases

GAS Pharyngitis Diagnostics Market Report 2022-2030 with Major Vendor Landscape and Their Strategies

Rising Number of Deaths Due to Rheumatic Heart Diseases to Accelerate Market Growth

As per the report published by the U.S. National Health Statistics Report, GAS pharyngitis is one of the primary causes that has led to an increase in the number of patients being admitted to the emergency ward in the country. Moreover, group A beta-hemolytic streptococcus is one of the leading causes of streptococcal pharyngitis among adults and children. The diagnosis of strep throat is imperative and increasingly gaining momentum, owing to a surge in the number of deaths due to chronic rheumatic heart disease. GAS pharyngitis diagnostics has, thus, received a great amount of attention over the past few years and gained considerable traction across diagnostic laboratories, hospitals, and physician clinics worldwide.

Get the sample copy of report@

Companies in the GAS pharyngitis diagnostics market are affected by a range of challenges. At present, one of the biggest challenges within the GAS pharyngitis diagnostics market is providing accurate, efficient, and accessible diagnostics. However, with significant groundwork, an influx of new training programs, growing support from government organizations, and promising outcome from R&D activities, GAS pharyngitis diagnostics is likely to gain significant momentum during the forecast period. Due to these factors, the global GAS pharyngitis diagnostics market is expected to attain a market value of ~US$ 204 Mn by the end of 2027.

Rapid Test Kits to Retain Popularity; Culture Tests Gain Ground

GAS pharyngitis diagnostics continues to remain a major challenge due to which, opting for the right treatment remains a constant roadblock. In the current scenario, antibiotics are primarily used to treat pharyngitis from bacterial infection. However, due to the significant rise in antimicrobial resistance, the adoption of antibiotics is declining-a factor that is expected to encourage research activities and finding an accurate diagnosis.

Culture tests are predominantly regarded as the gold standard in the GAS pharyngitis diagnostics market. However, the downside of these culture-based tests includes the large time gap between sample collection and attaining results. Over the past decade, due to a significant amount of research and advancements in the medical field, an array of rapid tests have emerged within the GAS pharyngitis diagnostics market that is predominantly based on immunoassays and in recent times, on molecular assays. While immunoassays, including immunochromatographic assays, optical immunoassays, and enzyme immunoassays are deployed, molecular assays that are based on techniques such as polymerase chain reaction, DNA probes, and fluorescence in situ hybridization are also gaining considerable traction across the world.

Primary factors that are expected to accelerate the demand for rapid tests in the upcoming years include faster diagnostics and prevention of inappropriate use of antibiotics. At present, research and development activities are largely aimed at increasing the accuracy of rapid tests and make them more cost-effective. Despite the growing adoption of rapid tests, culture tests for antimicrobial susceptibility testing will continue to stay in demand. Rapid test kit is set to dominate the GAS pharyngitis diagnostics market in terms of market share and value.

Market Participants Focus on Development of New Assays for Faster Results

For companies operating within the current GAS pharyngitis diagnostics market, improving accuracy and speed of the overall diagnostic procedure is expected to be a major area of interest. Several companies are currently in the process of attaining approval from the U.S. Food and Drug Administration (FDA). Some of the major players involved in the market, including Quidel Corporation and Abbott, are increasingly allocating funds for the development of new assays and a host of healthcare products. For instance, in October 2018, Abbott revealed that the U.S. FDA approved the company’s Influenza A & B 2 and Strep A 2 molecular assays. In addition, with the development of new assays, GAS pharyngitis diagnostics results can be achieved at a faster rate. In addition, the recently developed assays can be deployed in both patient as well as inpatient settings, such as physician offices, emergency rooms, walk-in clinics, etc. With additional research, new and cost-effective GAS pharyngitis diagnostics solutions that are currently in the research phase are projected to enter the market.

View full report@

Analysts’ Viewpoint

The global GAS pharyngitis diagnostics market is expected to grow at a CAGR of 2.5% during the forecast period. Some of the key factors that will most likely influence the growth of the market include a consistent growth in the number of GAS pharyngitis patients, high focus on research and development, and promising results offered by rapid test kits and continual support from government bodies worldwide. While culture tests will continue to remain an integral part of the entire GAS pharyngitis diagnostics market, the demand for rapid test kits will remain higher during the forecast period. Companies should continue investing in research and development activities and focus on obtaining approval from the FDA for their new assays.

GAS Pharyngitis Diagnostics Market: Overview

Pharyngitis is inflammation of the pharynx, which is in the back of the throat. It is most often referred to simply as sore throat. Numerous viral and bacterial agents can cause pharyngitis and GAS pharyngitis is one of the bacterial infections caused by specially group A streptococcus.

The market for GAS pharyngitis diagnostic is likely to expand significantly, as the incidence of GAS pharyngitis rises, especially among adolescents

According to Regents of the University of California, every year, more than 600 million cases of pharyngitis are reported worldwide and group A streptococcus (gas) is responsible for more than 30% of pharyngitis infection. Moreover, group A streptococcus (GAS) is the trigger for post-infectious immune-mediated rheumatic heart disease, which kills more than 300,000 people annually.

GAS Pharyngitis Diagnostics: Market Drivers

Several companies, as a part of strategy, are investing a high proportion of their revenue in pipeline product development with an objective to generate tests with high efficacy, within a short period, along with research in first-in-type test candidates, which is driving the market. For instance, in 2019, GenePOC Inc., received the U.S. FDA clearance for GenePOC Strep A assay. The GenePOC Strep A assay can provide results from up to eight samples as early as within 42 minutes for positive specimens and in approximately 70 minutes for negative specimens, without the need for culture confirmation.

Moreover, incidence and prevalence of GAS pharyngitis infection are gradually increasing across the globe. For instance, according to the CDC, report 2017, the incident rate of preventable invasive group A streptococcal disease increased from 5.8 per 100,000 in 2016 to 7.26 per 100,000 in 2017. This is also rising the demand for GAS pharyngitis diagnostic.

GAS Pharyngitis Diagnostics: Market Segmentation

Based on product, the global GAS pharyngitis diagnostics market has been divided into rapid test kit, culture test, and PCR-based test

Based on end user, the global GAS pharyngitis diagnostics market has been classified into hospitals, physician clinics, and diagnostic laboratories

Each segment of the GAS pharyngitis diagnostics market has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights

The report (GAS pharyngitis diagnostics) provides current and future revenue (US$ Mn) for each of these segments from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (%CAGR) has been provided for each segment of GAS pharyngitis diagnostics market from 2019 to 2027, along with market size estimations.

Purchase Complete Report Now@

GAS Pharyngitis Diagnostics Market: Regional Overview

In terms of region, the global GAS pharyngitis diagnostics market has been split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further divided into major countries and sub-regions.

North America is expected to dominate the GAS pharyngitis diagnostics market during the forecast period. The GAS pharyngitis diagnostics market in Asia Pacific is estimated to expand at a high CAGR during the forecast period.

The current and future values in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2017 to 2027, with their CAGRs for the period from 2019 to 2027

The study also offers a list of recommendations, highlights, and useful insights of the GAS pharyngitis diagnostics market which would help new companies willing to enter the GAS pharyngitis diagnostics market and existing companies to increase market shares, and help in the decision-making process

GAS Pharyngitis Diagnostics Market: Major Players 

The report concludes with the company profiles section that includes key information about the major players in the global GAS pharyngitis diagnostics market

Key players analyzed in this report are

  • Quidel Corporation
  • BD
  • Abbott Laboratories
  • bioMérieux SA
  • Hoffmann-La Roche Ltd
  • Beckman Coulter, Inc. (Danaher)
  • Meridian Bioscience, Inc.
  • DiaSorin S.p.A.
  • Sekisui Diagnostics

Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Key Questions Answered in GAS Pharyngitis Diagnostics Market Report

  • What is the sales/revenue generated by each product type across all regions during the forecast period?
  • What are the opportunities in the global GAS pharyngitis diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is likely to expand at the fastest CAGR during the forecast period?
  • Which test kit types are expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What was the market share or position of different companies operating in the global market in 2018?

GAS pharyngitis diagnostics Market – Segmentation


  • Rapid Test Kit
  • Culture Test
  • PCR-based Test

End User

  • Physician Clinics
  • Diagnostic Laboratories
  • Hospitals


  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global GAS Pharyngitis Diagnostics Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Strategies of Top 3 Players Operating in the Market

5.2. Key Industrial Events

6. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by Product, 2017-2027

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Product, 2017–2027

6.3.1. Rapid Test Kit

6.3.2. Culture Test

6.3.3. PCR-based Test

6.4. Global GAS Pharyngitis Diagnostics Market Attractiveness, by Product

7. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by End-user, 2017-2027

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global GAS Pharyngitis Diagnostics Market Value Forecast, by End-user, 2017–2027

7.3.1. Physician Office

7.3.2. Diagnostic Laboratories

7.3.3. Hospitals

7.4. Global GAS Pharyngitis Diagnostics Market Attractiveness, by End-user

8. Global GAS Pharyngitis Diagnostics Market Analysis and Forecast, by Region, 2017-2027

8.1. Key Findings

8.2. Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global GAS Pharyngitis Diagnostics Market Attractiveness, by Region

9. North America GAS Pharyngitis Diagnostics Market Analysis and Forecast, 2017-2027


Purchase Complete Report Now@   

You can place an order or ask any questions, please feel free to contact | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

Show More

Related Articles

Check Also
Back to top button